VapoMi d a ou ces a multi-i g edie t dieta y suppleme t featu i g bota ical ext acts a d compou ds studied i cog itive esea ch.
The i t oductio of VapoMi d ep ese ts the additio of a fo mulatio positio ed withi the cog itive well ess suppleme t catego y. The p oduct combi es bota ical ext acts, a atu ally occu i g phospholipid, a d a ca iti e de ivative.
Vapo Mi d is desc ibed as a suppleme t i te ded fo cog itive suppo t. Howeve , the supplied i fo matio does ot establish that the fi ished fo mulatio imp oves memo y, co ce t atio , atte tio , o othe aspects of cog itive pe fo ma ce.
The a ou ceme t focuses o i g edie t compositio , scie tific backg ou d, a d espo sible suppleme t commu icatio .
VapoMi d Capsules is used as a alte ative p oduct desig atio i this d aft, subject to co fi matio that the p oduct is ma ufactu ed a d dist ibuted i capsule fo m.
The disclosed i g edie ts i clude:
Gi kgo Biloba: A bota ical ext act co tai i g atu ally occu i g flavo oids a d te pe e compou ds.St. Joh ’s Wo t: A flowe i g pla t i vestigated p ima ily fo its effects o mood a d associated physiological p ocesses.Phosphatidylse i e: A phospholipid atu ally fou d i cell memb a es, i cludi g those of e ve cells.N-Acetyl L-Ca iti e HCl: A ca iti e de ivative associated with cellula e e gy metabolism.Bacopa Mo ie i: A bota ical i g edie t t aditio ally used i Ayu vedic p actices a d i vestigated i cog itive esea ch.
Vapo Mi d combi es these compo e ts i a si gle dieta y suppleme t fo mulatio .
Although i dividual i g edie ts have bee exami ed i scie tific studies, thei i clusio i VapoMi d does ot establish that the combi atio p oduces measu able cog itive be efits.
Resea ch i volvi g i dividual compou ds ca ot automatically be applied to a fi ished multi-i g edie t p oduct.
The p ecise i g edie t qua tities, ext act sta da dizatio , se vi g size, a d complete ma ufactu i g specificatio s have ot bee supplied.
Cog itive fu ctio i cludes memo y, atte tio , lea i g, easo i g, i fo matio p ocessi g, a d decisio -maki g.
These p ocesses depe d o i te actio s betwee eu al etwo ks, eu ot a smitte s, cellula metabolism, a d ove all physiological health.
Seve al lifestyle a d medical facto s i flue ce cog itive fu ctio i g, i cludi g sleep, physical activity, ut itio , st ess, agi g, a d existi g health co ditio s.
Resea ch i to ut itio al app oaches to cog itive well ess has exami ed bota ical ext acts, phospholipids, ami o acid de ivatives, vitami s, a d mi e als.
The developme t of Vapo Mi d eflects the b oade use of multiple ut itio al i g edie ts withi dieta y suppleme t fo mulatio s.
Howeve , a p oduct’s i te ded pu pose should be disti guished f om cli ically demo st ated outcomes.
No fi ished-p oduct cli ical t ial i fo matio has bee p ovided to establish that VapoMi d Capsules imp oves cog itive pe fo ma ce.
Dieta y suppleme ts should ot eplace app op iate medical evaluatio o t eatme t fo memo y diso de s, dep essio , deme tia, o othe eu ological a d psychiat ic co ditio s.
Gi kgo biloba is de ived f om a t ee species with a lo g bota ical histo y.
Ext acts p epa ed f om gi kgo leaves co tai flavo oid glycosides, te pe e lacto es, a d othe atu ally occu i g compou ds.
Scie tific i vestigatio s have exami ed sta da dized gi kgo ext acts i elatio to memo y, cog itio , a d eu ological fu ctio i g.
Howeve , fi di gs have va ied acco di g to the study populatio , ext act compositio , dosage, a d esea ch methodology.
Available evide ce does ot establish that gi kgo eliably p eve ts deme tia o imp oves cog itive pe fo ma ce i healthy adults.
Withi Vapo Mi d, Gi kgo Biloba ep ese ts o e compo e t of the five-i g edie t fo mulatio .
The co ce t atio a d sta da dizatio of the ext act would be eleva t to evaluati g its cha acte istics.
Gi kgo p epa atio s may i c ease bleedi g isk, pa ticula ly whe used alo gside a ticoagula t o a tiplatelet medicatio s.
I dividuals usi g these medicatio s should co sult a qualified healthca e p ofessio al befo e taki g suppleme ts co tai i g gi kgo.
St. Joh ’s Wo t, scie tifically k ow as Hype icum pe fo atum, is a flowe i g pla t histo ically used i he bal p epa atio s.
Its atu ally occu i g co stitue ts i clude hype ici , hype fo i , a d va ious flavo oids.
Ce tai sta da dized p epa atio s have bee i vestigated i cli ical studies i volvi g dep essive symptoms.
Howeve , this esea ch does ot establish that St. Joh ’s Wo t imp oves memo y, co ce t atio , o ge e al cog itive pe fo ma ce.
The i clusio of St. Joh ’s Wo t i VapoMi d should ot be i te p eted as evide ce that the fi ished p oduct t eats dep essio o othe psychiat ic co ditio s.
St. Joh ’s Wo t p ese ts sig ifica t medicatio i te actio co ce s.
It ca educe the effective ess of ume ous medicatio s, i cludi g ce tai ho mo al co t aceptives, a ticoagula ts, immu osupp essa ts, a d a tivi al medici es.
Combi i g St. Joh ’s Wo t with a tidep essa ts o othe se oto e gic medicatio s may i c ease the isk of se oto i sy d ome, a pote tially se ious co ditio .
Because Vapo Mi d i cludes this i g edie t, accu ate medicatio i te actio wa i gs a e especially impo ta t.
I dividuals taki g p esc iptio medicatio s should seek medical guida ce befo e co side i g VapoMi d Capsules.
Phosphatidylse i e is a atu ally occu i g phospholipid fou d i cellula memb a es th oughout the huma body.
It is pa ticula ly eleva t to the st uctu e a d fu ctio of e ve cell memb a es.
Phospholipids co t ibute to memb a e o ga izatio a d pa ticipate i cellula sig ali g p ocesses.
Resea che s have i vestigated suppleme tal Phosphatidylse i e i elatio to memo y a d othe aspects of cog itive fu ctio i g.
Some studies have epo ted fi di gs of i te est, but diffe e ces i study desig , dosage, fo mulatio , a d pa ticipa t cha acte istics limit b oad co clusio s.
The p ese ce of Phosphatidylse i e i Vapo Mi d does ot i depe de tly demo st ate imp oved cog itive pe fo ma ce.
Comme cial Phosphatidylse i e may be de ived f om diffe e t sou ces, i cludi g soy a d su flowe lecithi .
I fo matio about i g edie t sou ci g is eleva t fo i dividuals with alle gies o dieta y est ictio s.
VapoMi d would equi e ve ified i g edie t docume tatio to suppo t stateme ts about its Phosphatidylse i e sou ce a d co ce t atio .
N-Acetyl L-Ca iti e HCl is a fo m of acetyl-L-ca iti e, a de ivative of ca iti e.
Ca iti e pa ticipates i physiological p ocesses associated with fatty acid t a spo t a d cellula e e gy metabolism.
Acetyl-L-ca iti e has bee i vestigated i esea ch i volvi g eu ological fu ctio a d ce tai metabolic p ocesses.
Howeve , fi di gs i volvi g specific populatio s o cli ical co ditio s ca ot automatically be ge e alized to healthy adults.
The i clusio of this i g edie t i VapoMi d does ot establish that the fi ished suppleme t imp oves me tal cla ity, memo y, o co ce t atio .
The biological ole of a compou d should ot be co fused with p oof of a cli ical be efit f om suppleme tatio .
I g edie t qua tity, fo mulatio cha acte istics, a d i dividual health ci cumsta ces a e eleva t whe evaluati g dieta y suppleme ts.
I dividuals with existi g medical co ditio s should discuss suppleme t use with a qualified healthca e p ofessio al.
Bacopa mo ie i is a pla t fou d i wetla d e vi o me ts ac oss seve al egio s, i cludi g South Asia.
It has a histo y of use i t aditio al Ayu vedic p actices.
The pla t co tai s atu ally occu i g compou ds commo ly k ow as bacosides.
Bacopa ext acts have bee i vestigated i cli ical esea ch i volvi g memo y, lea i g, a d atte tio .
Some studies have epo ted cha ges i selected cog itive measu es followi g epeated suppleme tatio .
Howeve , esults va y, a d evide ce co ce i g pa ticula ext acts ca ot automatically be applied to all Bacopa-co tai i g p oducts.
Withi Vapo Mi d, Bacopa Mo ie i is i cluded as pa t of the five-i g edie t compositio .
The amou t of ext act a d its sta da dizatio would be impo ta t fo evaluati g the i g edie t.
Bacopa p epa atio s may cause gast oi testi al discomfo t, i cludi g ausea a d abdomi al symptoms, i some i dividuals.
The p ese ce of Bacopa Mo ie i i VapoMi d Capsules does ot establish that the fi ished suppleme t imp oves cog itive fu ctio i g.
Dieta y suppleme ts co tai i g
Each compo e t may have diffe e t abso ptio cha acte istics, biological activities, a d pote tial i te actio s.
Resea ch i volvi g i dividual i g edie ts does ot establish the safety o effective ess of thei combi atio .
VapoMi d b i gs togethe bota ical compou ds, a phospholipid, a d a ca iti e de ivative.
The i te actio of these compo e ts withi the fi ished fo mulatio has ot bee established by the i fo matio p ovided.
A complete scie tific assessme t of Vapo Mi d would equi e ve ified i g edie t qua tities, fo mulatio specificatio s, a d app op iate cli ical evide ce.
Studies i volvi g diffe e t dosages o p epa atio s ca ot automatically suppo t claims co ce i g VapoMi d Capsules.
Scie tific co clusio s should be based o the actual fo mulatio athe tha assumptio s d aw f om u elated p oducts.
This disti ctio is pa ticula ly impo ta t fo suppleme ts positio ed fo cog itive suppo t, whe e outcomes such as memo y a d atte tio equi e defi ed a d validated measu eme ts.
I g edie t t a spa e cy is a impo ta t compo e t of espo sible dieta y suppleme t commu icatio .
The disclosed VapoMi d fo mulatio ide tifies five i g edie ts, but additio al i fo matio would be ecessa y fo a comp ehe sive assessme t.
Releva t i fo matio i cludes se vi g size, i g edie t qua tities, bota ical ext act atios, sta da dizatio , i active i g edie ts, a d applicable wa i gs.
Ma ufactu i g specificatio s a e also impo ta t fo u de sta di g co siste cy a d quality.
Bota ical ext acts may va y depe di g o cultivatio co ditio s, ha vesti g methods, ext actio p ocedu es, a d sto age.
Fo example, Gi kgo Biloba a d Bacopa Mo ie i ext acts may co tai diffe e t co ce t atio s of selected pla t compou ds.
St. Joh ’s Wo t p epa atio s may also va y i thei co ce t atio s of hype ici a d hype fo i .
The Vapo Mi d fo mulatio would equi e docume ted specificatio s to substa tiate stateme ts about i g edie t co siste cy.
A y claims i volvi g thi d-pa ty labo ato y testi g, ma ufactu i g ce tificatio s, o egulato y complia ce should be suppo ted by ve ifiable docume tatio .
No i depe de t testi g esults o fi ished-p oduct cli ical studies have bee supplied fo VapoMi d.
Safety co side atio s a e pa ticula ly eleva t fo multi-i g edie t suppleme ts co tai i g bota icals with k ow medicatio i te actio s.
St. Joh ’s Wo t is associated with cli ically sig ifica t i te actio s i volvi g ume ous p esc iptio medicatio s.
Gi kgo Biloba may also i c ease bleedi g isk whe combi ed with ce tai medicatio s.
Othe i g edie ts may equi e additio al co side atio depe di g o dosage, medical histo y, a d co cu e t t eatme ts.
I dividuals with psychiat ic co ditio s, eu ological diso de s, ch o ic ill esses, o complex medicatio egime s should co sult healthca e p ofessio als befo e usi g u familia suppleme ts.
P eg a t o b eastfeedi g i dividuals should also seek medical guida ce.
The i t oductio of Vapo Mi d does ot establish that the suppleme t p eve ts cog itive decli e o t eats a y disease.
Respo sible commu icatio equi es sepa ati g i te ded ut itio al positio i g f om cli ically demo st ated effective ess.
Dieta y suppleme ts a e subject to egulato y equi eme ts that diffe f om those gove i g p esc iptio medicatio s.
I the U ited States, dieta y suppleme ts a e ge e ally ot app oved by the Food a d D ug Admi ist atio fo safety a d effective ess befo e ma keti g.
Ma ufactu e s a d dist ibuto s a e espo sible fo complyi g with applicable labeli g, ma ufactu i g, a d safety equi eme ts.
Claims co ce i g the t eatme t, p eve tio , o cu e of diseases equi e a app op iate egulato y basis.
The desc iptio of VapoMi d as a cog itive suppo t suppleme t should ot be i te p eted as evide ce of egulato y app oval fo t eati g eu ological co ditio s.
Simila ly, the i t oductio of Vapo Mi d does ot i depe de tly establish that the p oduct has u de go e cli ical evaluatio .
Accu ate labeli g a d app op iate safety disclosu es emai impo ta t co side atio s fo co sume s a d healthca e p ofessio als.
VapoMi d is a multi-i g edie t dieta y suppleme t co tai i g Gi kgo Biloba, St. Joh ’s Wo t, Phosphatidylse i e, N-Acetyl L-Ca iti e HCl, a d Bacopa Mo ie i. It is positio ed fo cog itive suppo t, although its fi ished-p oduct effective ess has ot bee established.
Vapo Mi d is positio ed withi the cog itive well ess suppleme t catego y. Its i te ded pu pose should ot be i te p eted as p oof that it imp oves memo y, atte tio , o eu ological health.
No p oduct-specific cli ical evide ce has bee supplied demo st ati g imp oveme ts i memo y o co ce t atio . Resea ch i volvi g i dividual i g edie ts does ot establish the effective ess of the combi ed fo mulatio .
No. VapoMi d Capsules should ot be ep ese ted as a t eatme t fo Alzheime ‘s disease, deme tia, dep essio , o othe eu ological o psychiat ic diso de s.
The disclosed i g edie ts a e Gi kgo Biloba, St. Joh ’s Wo t, Phosphatidylse i e, N-Acetyl L-Ca iti e HCl, a d Bacopa Mo ie i.
Yes. St. Joh ’s Wo t ca i te act with ume ous p esc iptio medicatio s, while Gi kgo Biloba may i c ease bleedi g isk whe combi ed with ce tai medici es. P ofessio al medical guida ce is impo ta t befo e use.
No fi ished-p oduct cli ical t ial i fo matio has bee supplied. Studies i volvi g i dividual i g edie ts ca ot establish that the complete fo mulatio has bee cli ically tested.
Co sume s should exami e the ve ified Suppleme t Facts label, i g edie t qua tities, se vi g i st uctio s, wa i gs, a d ma ufactu e i fo matio . They should also co side existi g medical co ditio s a d medicatio i te actio s.
Vapo Mi d is positio ed withi the cog itive well ess suppleme t catego y.
The VapoMi d Capsules desig atio , ma ufactu e ide tity, official lau ch status, i g edie t qua tities, a d complete p oduct specificatio s equi e ve ificatio befo e publicatio .
The a ou ceme t p ovides i fo matio about the disclosed fo mulatio without asse ti g p ove cog itive be efits o the apeutic effective ess.
CONTACT: email add ess: suppo t@vapomi d.com
pho e umbe : 833-762-6319.
